Anne Marijn Kramer

1.3k total citations
16 papers, 425 citations indexed

About

Anne Marijn Kramer is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Anne Marijn Kramer has authored 16 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in Anne Marijn Kramer's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Anne Marijn Kramer is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Anne Marijn Kramer collaborates with scholars based in United Kingdom, United States and Taiwan. Anne Marijn Kramer's co-authors include Kenth Gustafsson, John Anderson, Jonathan Fisher, Anna Capsomidis, Heleen H. Van Acker, Barry Flutter, Talia Gileadi, Rebecca Wallace, Astrid Olsnes Kittang and Thomas Seidl and has published in prestigious journals such as Blood, Scientific Reports and Kidney International.

In The Last Decade

Anne Marijn Kramer

13 papers receiving 422 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anne Marijn Kramer 242 217 82 76 49 16 425
E. Dijke 350 1.4× 65 0.3× 35 0.4× 107 1.4× 15 0.3× 35 547
Stephen DeWall 93 0.4× 52 0.2× 31 0.4× 124 1.6× 38 0.8× 12 227
Miguel Ángel Vesga 211 0.9× 201 0.9× 47 0.6× 88 1.2× 27 0.6× 18 377
Blanca Molina 92 0.4× 100 0.5× 178 2.2× 44 0.6× 23 0.5× 31 346
Kathryn Hally 148 0.6× 32 0.1× 77 0.9× 102 1.3× 13 0.3× 23 321
Claire Weatherburn 167 0.7× 161 0.7× 180 2.2× 73 1.0× 8 0.2× 8 353
Mark T. Vander Lugt 179 0.7× 42 0.2× 250 3.0× 56 0.7× 22 0.4× 14 381
Ori Goldberg 152 0.6× 37 0.2× 22 0.3× 85 1.1× 18 0.4× 31 372
Julia Martínez-Sánchez 57 0.2× 31 0.1× 39 0.5× 69 0.9× 8 0.2× 20 233
Goichi Kageyama 60 0.2× 59 0.3× 13 0.2× 53 0.7× 15 0.3× 18 235

Countries citing papers authored by Anne Marijn Kramer

Since Specialization
Citations

This map shows the geographic impact of Anne Marijn Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Marijn Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Marijn Kramer more than expected).

Fields of papers citing papers by Anne Marijn Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Marijn Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Marijn Kramer. The network helps show where Anne Marijn Kramer may publish in the future.

Co-authorship network of co-authors of Anne Marijn Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Marijn Kramer. A scholar is included among the top collaborators of Anne Marijn Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Marijn Kramer. Anne Marijn Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Srinagesh, Hrishikesh K., Anne Marijn Kramer, John H. Baird, et al.. (2025). Clinical and Cytokine Features of Immune Effector Cell–Associated Hemophagocytic Lymphohistiocytosis–Like Syndrome. Blood Cancer Discovery. 7(2). 225–233.
2.
Kramer, Anne Marijn, Yiyun Chen, Hrishikesh K. Srinagesh, et al.. (2024). CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS). Blood. 144(Supplement 1). 911–911.
3.
Srinagesh, Hrishikesh K., John H. Baird, Neha Agarwal, et al.. (2023). CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-γ Cytokine Signature. Blood. 142(Supplement 1). 4839–4839. 3 indexed citations
4.
Su, Yi‐Jiun, Anne Marijn Kramer, Mark Hamilton, et al.. (2023). Manufacturing of a Subsequent Autologous CAR-T Product after Prior CAR-T Is Safe and Feasible. Blood. 142(Supplement 1). 1037–1037.
5.
Heimel, Patrick, Gunpreet Oberoi, Anne Marijn Kramer, et al.. (2022). Mapping the functional anatomy and topography of the cardiac autonomic innervation for selective cardiac neuromodulation using MicroCT. Frontiers in Cell and Developmental Biology. 10. 968870–968870. 3 indexed citations
6.
Lang, Miriam, Petra Lujza Szabó, Anne Marijn Kramer, et al.. (2020). Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System. Journal of Visualized Experiments. 1 indexed citations
7.
Capsomidis, Anna, Heleen H. Van Acker, Jonathan Fisher, et al.. (2017). Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation. Molecular Therapy. 26(2). 354–365. 206 indexed citations
8.
Barisa, Marta, Anne Marijn Kramer, Dale Moulding, et al.. (2017). E. coli promotes human Vγ9Vδ2 T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner. Scientific Reports. 7(1). 22 indexed citations
9.
10.
Kramer, Anne Marijn, Sara Ghorashian, Gordon Weng-Kit Cheung, et al.. (2016). Construction and Pre-Clinical Evaluation of a New Anti-CD19 Chimeric Antigen Receptor. Blood. 128(22). 1627–1627. 3 indexed citations
11.
Kittang, Astrid Olsnes, Shahram Kordasti, Benedetta Costantini, et al.. (2015). Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome. OncoImmunology. 5(2). e1062208–e1062208. 96 indexed citations
12.
Fisher, Jonathan, Anne Marijn Kramer, Kenth Gustafsson, & John Anderson. (2014). Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy. OncoImmunology. 4(3). e973808–e973808. 11 indexed citations
13.
Kramer, Anne Marijn, Mengyong Yan, Karl S. Peggs, John Anderson, & Kenth Gustafsson. (2014). Tumor-Associated Antigen Presentation by γδ T-Cells in Cancer Immunotherapy. Blood. 124(21). 1411–1411. 1 indexed citations
14.
Kramer, Anne Marijn, Karlijn J. van Stralen, Kitty J. Jager, et al.. (2011). Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney International. 80(10). 1092–1098. 56 indexed citations
15.
Youns, Mаhmoud, Yujie Fu, Yuangang Zu, et al.. (2010). Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics. Naunyn-Schmiedeberg s Archives of Pharmacology. 382(3). 221–234. 21 indexed citations
16.
Kramer, Anne Marijn, et al.. (1996). Study of polymorphism of a novel antiulcer drug. European Journal of Pharmaceutical Sciences. 4. S182–S182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Dijke Breakdown of academic impact, for papers by Stephen DeWall Breakdown of academic impact, for papers by Miguel Ángel Vesga Breakdown of academic impact, for papers by Blanca Molina Breakdown of academic impact, for papers by Kathryn Hally Breakdown of academic impact, for papers by Claire Weatherburn Breakdown of academic impact, for papers by Mark T. Vander Lugt Breakdown of academic impact, for papers by Ori Goldberg Breakdown of academic impact, for papers by Julia Martínez-Sánchez Breakdown of academic impact, for papers by Goichi Kageyama
Rankless by CCL
2026